Skip to main content
. 2021 Dec 2;3(1):100194. doi: 10.1016/j.xinn.2021.100194

Figure 4.

Figure 4

Correlation of immune checkpoints in metastatic tumors with ICB treatment

(A and B) The Spearman's correlation of pairwise immune checkpoints in metastatic melanomas with anti-PD-1 in pre-treatment samples (A) and on-treatment samples (B).

(C) The Spearman's correlation of CYT and expression of checkpoints in five ICB pre-treatment datasets. Sample information is listed in Table S5.